INDICATIONS:

HORSES: Indicated for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. It is also Indicated for the alleviation of visceral pain associated with colic in the horse. Flunixin is four times as potent on a mg-per-mg basis as phenylbutazone as measured by the reduction in lameness and swelling in the horse. For Intravenous and Intramuscular use in horses.

CATTLE: Indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis. Flunixin persists in inflammatory tissues and is associated with anti-inflammatory properties which extend well beyond the period associated with detectable plasma drug concentrations. Only for Intravenous Use in Beef and Dairy Cattle. Not for Use in Dry Dairy Cows and Veal Calves.

FDA approved under ANADA #200-781; this product is considered a generic equivalent
to the reference product, Banamine®.

Available in:
• 100 mL, 250 mL and 500 mL multi-dose, rubber-stoppered, amber glass vials.